HIPK2 and neoplasm: In particular, a screening for genetic alterations in radiation-induced thymic lymphomas demonstrated that Hipk2 is a haploinsufficient tumor suppressor gene in vivo, showing loss of one Hipk2 allele in 30 % of the tumors and increased susceptibility of Hipk2+/− mice to radiation-induced thymic lymphoma [45].